Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma

NCT00323570 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Acquired Bleeding Disorder
Trauma

Interventions

DRUG: activated recombinant human factor VII

Sponsor

Novo Nordisk A/S